pros and cons of glp-1 drugs 2026 Employee Benefits Trends: Should You Cover GLP‑1s for Weight Loss? GLP-1 Medications: Everything You Need
Description
A lower, fixed dose for those who want a gentle, mindful, cosmetic approach rather than full dose weight loss
The global GLP-1 market is estimated to grow from USD 49.3 billion in the current year to USD 157
These diet
GLP-1RAs reduce events linked to atherogenic cardiovascular disease (especially ischemic stroke) and also renal outcomes (FLOW trial with semaglutide), with a limited effect on heart failure
Retatrutide vs Semaglutide: Evidence-based comparison of the investigational triple GIP/GLP-1/glucagon agonist versus the FDA-approved GLP-1 agonist
Your provider reviews the full safety profile with you before you begin
